Literature DB >> 28745124

Dysfunction of the foetal arterial duct results in a wide spectrum of cardiovascular pathology.

Marc Gewillig1, Stephen C Brown1,2, Mieke Roggen1, Benedicte Eyskens1, Ruth Heying1, Patrice Givron1, Bjorn Cools1, Luc de Catte1.   

Abstract

OBJECTIVE: Foetal ductal problems may have various cardiopulmonary consequences. This study aimed to identify the spectrum of ductus arteriosus (DA) dysfunction (closure, constriction, kinking, aneurysm and thrombosis) and the resultant clinical and echocardiographic presentation in foetuses and neonates. METHODS AND
RESULTS: This is a retrospective analysis of serial pre- and post-natal data of 27 cases of foetal ductal dysfunction diagnosed at a median gestational age of 33 weeks (range 20-39). The most common abnormalities observed were premature closure of the DA in 56% (15/27) and constriction in 29% (8/27). Right ventricular hypertrophy was present in 75% (n = 11/15) of foetuses with premature DA closure, while ventricular dilation (4/7, 57%) was a more common feature in foetuses with ductal constriction. After birth, 63% (17/27) of new borns presented with cyanosis and pulmonary hypertension that required active treatment. Three infants died after birth. Abnormalities resolved spontaneously after birth in about 50% of patients. In some children, pulmonary valve stenosis and regurgitation was progressive and required further treatment.
CONCLUSIONS: An abnormal right heart on foetal four-chamber ultrasound view should alert the sonographer to the possible presence of foetal ductal dysfunction. Ductal occlusion, transient or fixed constriction, kinking and aneurysm formation are associated with foetal cardiopulmonary sequelae. Symptoms and pathology is probably related to the type, foetal age, rapidity of progression and duration of intrauterine ductal dysfunction. Correspondingly, clinical outcomes vary ranging from little or no symptoms to severe respiratory distress and even foetal or neonatal death.

Entities:  

Keywords:  Foetal; ductus; dysfunction; heart abnormality; hypertrophy

Mesh:

Year:  2017        PMID: 28745124     DOI: 10.1080/00015385.2017.1314876

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  4 in total

1.  Maternal paracetamol intake and fetal ductus arteriosus constriction/closure: comprehensive signal evaluation using the Austin Bradford Hill criteria.

Authors:  Manfred Hauben; Stephen Bai; Eric Hung; Kasia Lobello; Charles Tressler; Vincent P Zucal
Journal:  Eur J Clin Pharmacol       Date:  2021-01-07       Impact factor: 2.953

2.  The Additional Role of the 3-Vessels and Trachea View in Screening for Congenital Heart Disease.

Authors:  Roxana Gireadă; Demetra Socolov; Elena Mihălceanu; Roxana Matasariu; Alexandra Ursache; Mona Akad; Iuliana Bujor; Ioana Scripcariu; Radu Florin Popa; Răzvan Socolov
Journal:  Medicina (Kaunas)       Date:  2022-02-10       Impact factor: 2.430

Review 3.  Foetal ductus arteriosus constriction unrelated to non-steroidal anti-Inflammatory drugs: a case report and literature review.

Authors:  Giovanna Battistoni; Ramona Montironi; Jacopo Di Giuseppe; Luca Giannella; Giovanni Delli Carpini; Alessandra Baldinelli; Marco Pozzi; Andrea Ciavattini
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

4.  Maternal paracetamol intake and fetal ductus arteriosus constriction or closure: a case series analysis.

Authors:  Karel Allegaert; Paola Mian; Alexandre Lapillonne; John N van den Anker
Journal:  Br J Clin Pharmacol       Date:  2018-10-25       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.